Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
By Lilian Grigorian
In May for the fifteenth time in a row the International Symposium on Cell Therapy and Cardiovascular Innovations (TECAM, www.cardiovascularcelltherapy.com) took place in Madrid.
This annual meeting organized by the Working Group on Cardiovascular Regenerative and Reparative Medicine gathers leading experts in the field from all over the world. Basic and clinical scientists have an opportunity to share their expertise, to discuss the hot topics and decide on future steps in the development of the regenerative-reparative medicine. In fact, members of the Transnational AllianCe for regenerative Therapies in Cardiovascular Syndromes (TACTICS) have a special session during the Symposium where they decide on relevant global position statements and papers, organize future meetings and define priority actions to ensure the right progress of the discipline.
For young scientists interested in cardiovascular regenerative and reparative medicine, the TECAM is a great and unique opportunity to just in two days grab a whole picture on the most disruptive innovations, have an opportunity to meet the experts and ask them questions directly, to present their research results. Young investigators are encouraged to present their work in a poster format or orally during a specially dedicated session. This year we were delighted by the very interesting talks on the role of endocannabinoid system in dystrophic cardiomyopathy (by Aoife Gowran from Dr Pompilio’s group, Milan, Italy), the fetostopic therapy (by Rodrigo Ruano from Dr Terzic’s group, Rochester, USA) and the novel 3D technologies (by Manuel Mazo from Dr Prosper’s group, Pamplona, Spain). As usual, two posters were selected for the best posters session. The awardees this year were Kmiotek-Wasylewska (Dr Zuba-Surma’s group, Krakow, Poland) for their work on induced pluripotent stem cells-derived extracellular vesicles and Mathiasen (Dr Kastrup’s group, Copenhagen, Denmark) for the safety study, using cryopreserved off-the-shelf allogeneic adipose derived stromal cells.
If you are a young scientist, basic or clinical, from any corner of the world, interested in regenerative medicine, the free membership within the ESC WG on Cardiovascular Regenerative and Reparative Medicine will open you the possibility to connect with the network of experts and other members of the group, automatically become a member of the ESC and much more.
To find out more on the application process, visit our webpage.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved